The pediatric group included Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL) and MUM1-positive-lymphoma in 7, 3 and 2 cases, respectively. The gene discussed is IRF4; the disease is diffuse large B-cell lymphoma.